Breast density alone found not to be a factor for breast cancer risk

December 02, 2015

Although several studies suggest that women with denser breast tissue have an increased risk of breast cancer, a new study by Johns Hopkins researchers discredits breast density as a risk factor in and of itself, instead concluding that age and body fat, especially in the upper belly, contribute to the breast cancer seen in many patients.

"Many studies that link breast density to breast cancer risk used data from mammograms, which can't accurately measure breast density," says Wenlian Zhu, Ph.D., a research associate in the Johns Hopkins University School of Medicine and a member of the team reporting the study results online Oct. 21, 2015, in European Radiology. "Our research may help dispel the assertion that breast density alone is something women should be worried about with regard to their breast cancer risk, and it may help minimize confusion and unnecessary concern."

Breast density notification laws have been put into effect in 24 states. According to Zhu, such laws mandate that the presence of dense breast tissue and its potential to mask tumors be communicated to the patient. The breast density law in some states also mentions the "increased breast cancer risk associated with dense breast." The Centers for Disease Control and Prevention lists dense breasts by mammogram as one of the factors that increases breast cancer risk.

To confirm whether breast density is an independent risk factor for breast cancer, Zhu, working with colleagues from the Johns Hopkins Kimmel Cancer Center, examined 3-D, T1-weighted MRI breast scans done between 2007 and 2014 on 410 patients with invasive cancer in one breast, 73 patients with ductal carcinoma in situ, and 361 women with no evidence of breast cancer. The imaging technique used offers high contrast between fatty and dense glandular breast tissues, giving a more accurate measurement of breast density.

Along with information on breast density, the researchers also used MRI scans to assess adiposity using measurements of the fatty tissue thickness in the upper abdomen right beneath the breast. Then, investigators searched for links among breast cancer and breast density, body adiposity, and subjects' ages. The researchers found strong correlation between both age and adiposity with breast cancer. However, the correlation between breast cancer and breast density alone was insignificant.

Zhu says one likely explanation for their finding is that women with the densest breasts tended to be young and lean, both factors aligned with lower breast cancer risk. "Grouping all women with dense breasts into an elevated risk category could therefore be misleading and may cause unnecessary anxiety for many women," she says. "If further studies expand and confirm our research, we may be able to offer reassurance to many young and lean women with dense breasts."

Zhu cautions that her study did not specifically examine the interactions among age, adiposity and breast density for older women. Testing whether breast density is associated with breast cancer in this population will be the subject of future research, she says.
The American Cancer Society estimates that nearly 280,000 new cases of breast cancer will be diagnosed in 2015.

Other Johns Hopkins researchers who participated in this study include Peng Huang, Katarzyna J. Macura and Dmitri Artemov.

This research was supported by the National Cancer Institute under grant number CA154738.

Johns Hopkins Medicine

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to